首页> 外国专利> The angiotensin conversion enzyme inhibiter which designates the remedy of the heart vascular disease as purpose, the aldosterone antagonist of the side effect reduction tonnage and combination medical therapy of the diuretic

The angiotensin conversion enzyme inhibiter which designates the remedy of the heart vascular disease as purpose, the aldosterone antagonist of the side effect reduction tonnage and combination medical therapy of the diuretic

机译:血管紧张素转化酶抑制剂,其目的是治疗心血管疾病,减少副作用的醛固酮拮抗剂以及利尿剂的联合药物治疗

摘要

Combinations of an ACE inhibitor, an aldosterone receptor antagonist and a diuretic, i.e., "triple therapy" combinations, are described for use in treatment of circulatory disorders. of particular interest are triple therapies using captopril or enalapril co-administered with a low-dose of spironolactone and furosemide. This triple therapy would be particularly useful to treat or prevent the progression of congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects such as hyperkalemia.
机译:描述了ACE抑制剂,醛固酮受体拮抗剂和利尿剂的组合,即“三联疗法”组合,其用于治疗循环系统疾病。特别令人感兴趣的是使用卡托普利或依那普利与低剂量螺内酯和速尿共同给药的三联疗法。这种三重疗法在治疗或预防充血性心力衰竭的发展同时避免或减少醛固酮-拮抗剂引起的副作用(如高钾血症)时特别有用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号